Cargando…

Dexmedetomidine does not produce vasocontraction on human isolated gastroepiploic artery

BACKGROUND: Recently, the addition of dexmedetomidine to sedation regimens after cardiac surgery had been reported and there is a possibility that dexmedetomidine can cause vasoconstriction. Vasopressin has been used as a prophylactic treatment for refractory vasodilatory shock during coronary arter...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Won-Sung, Baek, Seung-Hoon, Lee, Sang Kwon, Jeon, Tae Yong, Kim, Hee-Young, Shin, Sang Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Anesthesiologists 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121090/
https://www.ncbi.nlm.nih.gov/pubmed/21738846
http://dx.doi.org/10.4097/kjae.2011.60.6.428
_version_ 1782206796512886784
author Kim, Won-Sung
Baek, Seung-Hoon
Lee, Sang Kwon
Jeon, Tae Yong
Kim, Hee-Young
Shin, Sang Wook
author_facet Kim, Won-Sung
Baek, Seung-Hoon
Lee, Sang Kwon
Jeon, Tae Yong
Kim, Hee-Young
Shin, Sang Wook
author_sort Kim, Won-Sung
collection PubMed
description BACKGROUND: Recently, the addition of dexmedetomidine to sedation regimens after cardiac surgery had been reported and there is a possibility that dexmedetomidine can cause vasoconstriction. Vasopressin has been used as a prophylactic treatment for refractory vasodilatory shock during coronary artery bypass graft (CABG). Also, vasopressin may play an important role in initiating spasms at the graft artery. Here we evaluate the direct effect of dexmedetomidine on isolated human gastroepiploic arteries and the synergistic effect of dexmedetomidine and vasopressin. METHODS: Discarded gastroepiploic arteries from elective subtotal gastrectomy (n = 10) were used in this study. We measured the level of contraction in isolated human gastroepiploic arteries induced by increasing concentrations of dexmedetomidine (10(-10) to 10(-6) M) with or without vasopressin (10(-10), 10(-9) M). Arterial contractions caused by increasing concentrations of vasopressin (10(-10) to 10(-7.5) M) with or without dexmedetomidine (10(-9), 10(-7) M) were also measured in the tissue samples. RESULTS: Supraclinical concentrations of dexmedetomidine elicited contractions at concentrations of 10(-7) M and 10(-6) M (P < 0.05 versus resting tension). The same concentrations of dexmedetomidine (10(-7), 10(-6) M) significantly enhanced vasopressin-induced contractions (P < 0.05 versus vasopressin-induced contraction). Vasopressin produced concentration-dependent contractions and vasopressin (10(-10), 10(-9.5), 10(-9) M) also increased the intensity of dexmedetomidine (10(-7) M) induced contractions. CONCLUSIONS: There was a synergistic effect between supraclinical doses of dexmedetomidine and vasopressin on the degree of contraction in isolated human gastroepiploic arteries. However, a sedative dose of dexmedetomidine (clinical dose: 0.2-0.7 µg/kg/hr, plasma concentration: 0.36-1.25 ng/ml) did not enhance vasopressin induced-contraction in isolated human gastroepiploic arteries.
format Online
Article
Text
id pubmed-3121090
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher The Korean Society of Anesthesiologists
record_format MEDLINE/PubMed
spelling pubmed-31210902011-07-07 Dexmedetomidine does not produce vasocontraction on human isolated gastroepiploic artery Kim, Won-Sung Baek, Seung-Hoon Lee, Sang Kwon Jeon, Tae Yong Kim, Hee-Young Shin, Sang Wook Korean J Anesthesiol Experimental Research Article BACKGROUND: Recently, the addition of dexmedetomidine to sedation regimens after cardiac surgery had been reported and there is a possibility that dexmedetomidine can cause vasoconstriction. Vasopressin has been used as a prophylactic treatment for refractory vasodilatory shock during coronary artery bypass graft (CABG). Also, vasopressin may play an important role in initiating spasms at the graft artery. Here we evaluate the direct effect of dexmedetomidine on isolated human gastroepiploic arteries and the synergistic effect of dexmedetomidine and vasopressin. METHODS: Discarded gastroepiploic arteries from elective subtotal gastrectomy (n = 10) were used in this study. We measured the level of contraction in isolated human gastroepiploic arteries induced by increasing concentrations of dexmedetomidine (10(-10) to 10(-6) M) with or without vasopressin (10(-10), 10(-9) M). Arterial contractions caused by increasing concentrations of vasopressin (10(-10) to 10(-7.5) M) with or without dexmedetomidine (10(-9), 10(-7) M) were also measured in the tissue samples. RESULTS: Supraclinical concentrations of dexmedetomidine elicited contractions at concentrations of 10(-7) M and 10(-6) M (P < 0.05 versus resting tension). The same concentrations of dexmedetomidine (10(-7), 10(-6) M) significantly enhanced vasopressin-induced contractions (P < 0.05 versus vasopressin-induced contraction). Vasopressin produced concentration-dependent contractions and vasopressin (10(-10), 10(-9.5), 10(-9) M) also increased the intensity of dexmedetomidine (10(-7) M) induced contractions. CONCLUSIONS: There was a synergistic effect between supraclinical doses of dexmedetomidine and vasopressin on the degree of contraction in isolated human gastroepiploic arteries. However, a sedative dose of dexmedetomidine (clinical dose: 0.2-0.7 µg/kg/hr, plasma concentration: 0.36-1.25 ng/ml) did not enhance vasopressin induced-contraction in isolated human gastroepiploic arteries. The Korean Society of Anesthesiologists 2011-06 2011-06-17 /pmc/articles/PMC3121090/ /pubmed/21738846 http://dx.doi.org/10.4097/kjae.2011.60.6.428 Text en Copyright © the Korean Society of Anesthesiologists, 2011 http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Experimental Research Article
Kim, Won-Sung
Baek, Seung-Hoon
Lee, Sang Kwon
Jeon, Tae Yong
Kim, Hee-Young
Shin, Sang Wook
Dexmedetomidine does not produce vasocontraction on human isolated gastroepiploic artery
title Dexmedetomidine does not produce vasocontraction on human isolated gastroepiploic artery
title_full Dexmedetomidine does not produce vasocontraction on human isolated gastroepiploic artery
title_fullStr Dexmedetomidine does not produce vasocontraction on human isolated gastroepiploic artery
title_full_unstemmed Dexmedetomidine does not produce vasocontraction on human isolated gastroepiploic artery
title_short Dexmedetomidine does not produce vasocontraction on human isolated gastroepiploic artery
title_sort dexmedetomidine does not produce vasocontraction on human isolated gastroepiploic artery
topic Experimental Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121090/
https://www.ncbi.nlm.nih.gov/pubmed/21738846
http://dx.doi.org/10.4097/kjae.2011.60.6.428
work_keys_str_mv AT kimwonsung dexmedetomidinedoesnotproducevasocontractiononhumanisolatedgastroepiploicartery
AT baekseunghoon dexmedetomidinedoesnotproducevasocontractiononhumanisolatedgastroepiploicartery
AT leesangkwon dexmedetomidinedoesnotproducevasocontractiononhumanisolatedgastroepiploicartery
AT jeontaeyong dexmedetomidinedoesnotproducevasocontractiononhumanisolatedgastroepiploicartery
AT kimheeyoung dexmedetomidinedoesnotproducevasocontractiononhumanisolatedgastroepiploicartery
AT shinsangwook dexmedetomidinedoesnotproducevasocontractiononhumanisolatedgastroepiploicartery